<DOC>
	<DOCNO>NCT03024307</DOCNO>
	<brief_summary>This randomise trial efficacy Outpatient Pharmacy Clinical Services Program ( OPCSP ) adherence clinical outcome among patient rheumatic diseases.The purpose study evaluate : 1. rate medication adherence OPCSP program compare usual care integrate health care system . 2. total direct cost clinical outcome OPCSP program compare usual care integrate health care system .</brief_summary>
	<brief_title>The Effect OPCSP Adherence Clinical Outcomes Among Patients With Rheumatic Diseases</brief_title>
	<detailed_description>This randomise trial efficacy Outpatient Pharmacy Clinical Services Program ( OPCSP ) adherence clinical outcome among patient rheumatic diseases.Three type rheumatic disease include study , Systemic lupus erythematosus ( SLE ) , Ankylosing spondylitis ( AS ) , Rheumatoid Arthritis ( RA ) . The purpose study evaluate : 1. rate medication adherence OPCSP program compare usual care integrate health care system . 2. total direct cost clinical outcome OPCSP program compare usual care integrate health care system .</detailed_description>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<criteria>Willingness subject participate study , proven sign informed consent ; Systemic lupus erythematosus ( SLE ) , define meeting least 4 11 classification criterion American College Rheumatology classification systemic lupus erythematosus , either sequentially coincidentally . The 4 criterion n't need present time study enrollment ; Patients fulfil American College Rheumatology criterion RA AS ; Patients unwilling sign inform consent ; Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pharmaceutical Care</keyword>
	<keyword>Medication Adherence</keyword>
	<keyword>Direct Costs</keyword>
</DOC>